Thanks, Rick (I owe you an acknowledgement on a TLRK post):
Maybe SCIO management IS doing things right. In the cc, the CSO or VP Medicine indicated that other molecules targeting p38 were in pre-clinical testing backing up S-469 lead candidate.
If I had been a long-standing follower of BT (I gravitated to following Peter, Rick, rkrw, Miljenko and others only in Feb 2001, or so) with a position in SCIO, I would probably have bailed at continuous disappointments in Calif Biotech and never looked back. Thus, there is something to be said for being late to the party--although the party seems a bit dull, depressed and played out recently.
And there would be no party at SI at all but for those mentioned above (+ Metcalf, Harold, BT Jim, Stefaan, tuck, Vector, nigel, ij (keen financial eye) and others I'm clumsy enough to have left out). Thank you ALL.
quid |
